Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MM-II for Knee Pain in Osteoarthritis
NCT04506463Phase 2Completed
- Sponsor
- Sun Pharma
- Start
- Dec 2020
- Primary completion
- May 2022
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 3
01
Overview
A Phase 2 trial of MM-II in osteoarthritis (OA), sponsored by Sun Pharma. Started Dec 2020; status: completed.
02
Drugs
MM-II
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04506463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04506463.